<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 6 Issue 1</issue_number>
<issue_period>2015 (January - March)</issue_period>
<title>IN VITRO ANTIMICROBIAL ACTIVITY OF CEREULIDE AND VALINOMYCIN COMPARE WITH CYCLIC D,L- α –PEPTIDES AND THEIR ENHANCED EFFECT </title>
<abstract>Cereulide and valinomycin are both cyclic depsipeptides with 12 stereogenic centers that have a very similar sequence in the structure. Both compounds are hexagonal cylinder-like framework and all the side chains stick outside of the framework. The framework of cyclic D,L-α-peptides were structured different from the cereulide and valinomycin which are performed by cyclic DDLL-peptides. The cyclic D,L-α-peptides consisted of an even number of alternating D- and L- α-amino acid which can adopt flat and stack to form hollow, b-sheet like tubular structures. The amino acid side chains are presented on the outside surface of the framework and the interior surface of such a tube is hydrophilic. In our studies, we found that the original cereulide and valinomycin demonstrated higher antimicrobial activity than the cyclic D,L-α-peptides which are synthesized by using cereulide and valinomycin as a model structure. Furthermore, the combinations of cereulide or valinomycin with clinically used drugs against fungi were found to enhance the antimicrobial efficacy by decreasing the MIC values between 2-128 times.</abstract>
<authors>ARTHIT MAKARASEN, NANTHAWAN REUK-NGAM, PIYACHAT CHUYSINUAN, CHAIYAWAT AONSRI, NITIRAT CHIMNOI, MINORU ISOBE AND SUPANNA TECHASAKUL</authors>
<keywords>Cereulide, Valinomycin, Cyclic peptide, D,L-Î±-peptides</keywords>
<pages>77-85</pages>
</article>
</Journal>
